Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane Antigen
- 22 August 2011
- journal article
- research article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 50 (39), 9167-9170
- https://doi.org/10.1002/anie.201102872
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Epigenetic effects of stress and corticosteroids in the brainFrontiers in Cellular Neuroscience, 2012
- Multimodal Tumor-Targeting Peptides Functionalized with Both a Radio- and a Fluorescent LabelBioconjugate Chemistry, 2010
- Multimodality Imaging of Gene Transfer with a Receptor-Based Reporter GeneJournal of Nuclear Medicine, 2010
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate CancerJournal of Medicinal Chemistry, 2010
- Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic MelanomaCancer Research, 2010
- A low molecular weight PSMA-based fluorescent imaging agent for cancerBiochemical and Biophysical Research Communications, 2009
- Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probeJournal of Biomedical Optics, 2009
- Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate CancerJournal of Medicinal Chemistry, 2008
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)Journal of Medicinal Chemistry, 2008
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate CancerClinical Cancer Research, 2008